Insights

Banner image with text: 'Stay informed with the latest IP news' and the following words listed: Insights, Interviews, Webinars.

The Patent Prosecution Highway expands

By Troels Peter Rørdam | Posted on May 31, 2012

I have previously written about the PPH MOTTAINAI agreement, which aims at easing the requirements for requesting patent examinations. The latest news is that the EPO (European Patent Office) entered the PPH MOTTAINAI agreement at the beginning of the year (29 January) and thus the PPH MOTTAINAI agreement has now been signed by a total of nine countries. With...

Tags: EPO, Japan, patent prosecution highway, USA

Awapatent at the 4th China IP Counsel Conference 2012

By Vibeke Warberg Rohde | Posted on May 25, 2012

On 22-23 May 2012 representatives from Awapatent participated in the 4th China IP Counsel Conference held in Shanghai. The program was very interesting with many different angles on IP, particularly on how to protect your IP in the best possible way. A representative from the Chinese Intellectual Property Office (SIPO) opened with a speech about the...

Tags: china, IP Counsel Conference, IP rights in China, Shanghai

High Court Decision Confirms Low Compensations to Inventors Employed to Invent

By Kim Garsdal Nielsen | Posted on May 16, 2012

Decisions are few when it comes to considering the inventor’s right to compensation in accordance with Section 8 of the Danish Act on Employee’s Inventions (Lov om arbejdstageres Opfindelser). Recently the High Court (Østre Landsret) has passed a decision in U.2012.420Ø, confirming that compensations to inventors employed to invent are low. In the case in...

Tags: compensation, inventions, inventor, inventor's right

India Grants the First Compulsory License

By Jeanette Jakobsson | Posted on March 30, 2012

The Compulsory License Application No. 1 of 2011, the first of its kind in the history of the Indian Patents Act 1970, concerns the anti-cancer drug Sorafenib, where the patentee is Bayer Corporation and the applicant for a compulsory license is Natco Pharma Limited. The anti-cancer drug Sorafenib, sold under the brand name NEXAVAR, is...

Tags: compulsory license, drug patents, India

Getting Personal in Sweden: Liability of Directors, Officers, and Owners for their Company’s IP Infringement

By Robin Berzelius | Posted on March 23, 2012

1. Introduction Picture a scenario where a plaintiff in an IP infringement case in Sweden has received a well earned final ruling in its favor, or perhaps gotten a preliminary injunction issued against an accused infringer. As the plaintiff is celebrating its success, it receives news that the infringer recently emptied its warehouses of infringing...

Tags: Infringement, personal liability, sweden

New Patent Prosecution Highway Agreement between the DKPTO and Russias ROSPATENT enters into force

By Troels Peter Rørdam | Posted on February 20, 2012

As mentioned in my previous blog entry dated 23 January 2012, the DKPTO announced that due to user demand efforts to establish a PPH-agreement with the Russian Patent Office had been initiated. Now, the efforts have matured into a PPH-agreement between DKPTO and ROSPATENT, which entered into force on 1 February 2012. Prosecution via the...

Tags: Denmark, patent prosecution highway, PPH, Russia

EPO Enlarged Board of Appeal repeats obligation to raise objections in time

By AWA | Posted on February 1, 2012

Last week, the European Patent Office released two new decisions by the Enlarged Board of Appeal on petitions for review, R 2/11 and R 10/11. Both the underlying petitions were based on what the petitioners regarded as fundamental procedural defects before respective Boards of Appeal 3.2.04 and 3.2.03. Both cases are appeals from opposition proceedings. In R...

Tags: Board of Appeal, claim amendments, EPO

Recent contributors

Laura Stravinskaite

Laura Stravinskaite

Senior Associate, Attorney at Law

Ai-Leen Lim

Ai-Leen Lim

Partner, Attorney at Law, Group Vice President

Ashley Zhao

Ashley Zhao

Partner, Attorney at Law, Business Area Manager

Troels Peter Rørdam

Troels Peter Rørdam

Senior Counsel, European Patent Attorney

Mikkel Roed Trier

Mikkel Roed Trier

Partner, European Patent Attorney, UPC Representative, Business Area Manager